Hexapeptide-33 (CAS: 1192135-40-2) Anti-pigmentation Peptide

PRODUCT PARAMETERS

Hexapeptide-33

CAS: 1192135-40-2

Anti-pigmentation/Brightening

Hexapeptide-33 intercepts melanin triggers via GPCR antagonism, inhibits tyrosinase, and prevents PIH for high-precision skin brightening.

Description
About Us
Request A Quote

Description

Hexapeptide-33 Basic Chemical Information

Hexapeptide-33 Powder Specification

Hexapeptide-33 Solution Specification

The mechanism of Hexapeptide-33

Advantage and Benefit

FAQs

A:Hexapeptide-33 (sequence Ser‑Phe‑Lys‑Leu‑Arg‑Tyr‑NH₂) inhibits melanin synthesis through two complementary pathways. It acts as a direct tyrosinase inhibitor, reducing melanin formation in B16 melanoma cells. Additionally, it functions as an endothelin‑1 receptor antagonist, blocking ET‑1 signaling that stimulates melanogenesis. In vitro, it reduces melanin production by over 40% and decreases tyrosinase protein levels in B16 cells. A 2009 study (Lee et al., Int J Pept Res Ther 15:281–286) first reported these anti‑melanogenic and antioxidant properties for this peptide.

A: Unlike AHAs or Vitamin C which can be irritating, Hexapeptide-33 is a Biomimetic Signal Blocker. It targets GPCRs (G-Protein-Coupled Receptors) on melanocytes to interrupt the “tanning command.” By blocking the signaling cascade that leads to melanin synthesis, it achieves a powerful brightening effect while remaining completely soothing and safe for sensitive skin.

A: This is where Hexapeptide-33 truly shines. Because of its “Wound-repair” heritage, it is exceptionally effective at preventing and fading PIH (dark spots left by acne or procedures). It calms the inflammatory signals that usually trigger melanocytes to overproduce pigment, ensuring that repaired skin heals with a clear, even tone.

A: Yes. By consistently inhibiting new melanin production and promoting healthy keratinocyte turnover, it prevents existing spots from darkening while allowing the skin to naturally shed pigmented cells. This leads to a visible “global brightening” effect and a more radiant, uniform complexion.

A: It is a perfect synergy partner. While Niacinamide blocks melanin transfer and Tranexamic Acid targets plasmin, Hexapeptide-33 works at the earliest signaling stage. Combining them creates a multi-layered defense against hyperpigmentation, covering every step from “signal” to “stain”.

A: UV exposure and laser treatments trigger a massive release of α-MSH (melanocyte-stimulating hormone). Hexapeptide-33 steps in as a molecular shield, neutralizing the stress signals that cause “rebound” pigmentation. It’s the ideal active for ensuring that skin stays bright after being challenged by external stressors.

GENOPEP GROUP | The Engine of Your Peptide Innovation

GENOPEP Group is a leading global peptide technology solutions provider, specializing in R&D, manufacturing, and commercialization in the fields of skin science and biopharmaceuticals. Supported by advanced scientific capabilities and a fully integrated supply chain, we deliver efficient and reliable innovation support to skincare brands worldwide.

We focus on three key service areas, empowering partners throughout the entire product lifecycle from concept to market:

  • Active Ingredients and Formulation Development – Grounded in cutting-edge research, we provide high-efficacy skincare ingredients, ingredient complexes, and complete formulation solutions.
  • End-to-End Production Support – Covering the full journey from lab-scale R&D and pilot optimization to commercial manufacturing, ensuring consistent product quality and reliable supply.
  • Custom Synthesis Services – With strong capabilities in novel molecule development, we specialize in the design, synthesis, and preparation of peptide-based novel ingredients and related reference standards.

We believe in technology-driven products and collaboration-driven value. GENOPEP is not just a supplier—we are your trusted innovation partner, dedicated to co-creating the next generation of skincare solutions with you.

REQUEST A QUOTE

REQUEST A QUOTE